Quantitative and functional impairment of pulmonary CD4+CD25+Foxp+ Treg cells in pediatric asthma patients has been observed, demonstrating that CD4+CD25+FOXP3+ Treg cells can reverse established allergic airway inflammation and prevent airway remodeling [44]. The gene discussed is FOXP3; the disease is asthma.